The Precision Peptide Company Inc.

The Precision Peptide Company Inc. recorded three insider acquisitions during the recent period. Director Pratapvir Sandhu executed these purchases, totaling 385,000 shares. These transactions represent a cumulative investment of 166,725 CAD. No divestments occurred, reflecting a singular focus on increasing equity stakes by this board member.
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.8
Sandhu, Pratapvir Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
306.93
Quantity 23,573 +27.8%
Value CA$4,269,110
3.8
Sandhu, Pratapvir Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
440.82
Quantity 33,317 +3.4%
Value CA$557,707
3.8
Sandhu, Pratapvir Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
494.16
Quantity 88,789 +36.5%
Value CA$994,370
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-07-17 2026-07-17 B Purchase

Director of Issuer

Non-Executive Director
23,573 +27.8%
306.93
CA$4,269,110
23,573 +27.8% 306.93 CA$4,269,110
2026-07-17 2026-07-17 B Purchase

Director of Issuer

Non-Executive Director
33,317 +3.4%
440.82
CA$557,707
33,317 +3.4% 440.82 CA$557,707
2026-06-23 2026-06-02 B Purchase

Director of Issuer

Non-Executive Director
88,789 +36.5%
494.16
CA$994,370
88,789 +36.5% 494.16 CA$994,370
Explore more

More insider trading research around The Precision Peptide Company Inc.